Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Very-low-dose aspirin and surveillance colonoscopy is cost-effective in secondary prevention of colorectal cancer in individuals with advanced adenomas: network meta-analysis and cost-effectiveness analysis

Fig. 2

Comparative efficacy and safety of chemopreventive agents for recurrence of advanced adenomas in network meta-analysis. Note: Outcomes are expressed as risk ratio (RR, with 95% confidence interval). Comparisons should be read from left to right. RR < 1 indicates that the treatment specified in the column is more efficacious in preventing recurrent advanced adenomas. For risk of serious adverse events, RR < 1 indicates that the treatment specified in the row is safer. Bold cells are significant. Abbreviations: ASALD, low-dose-aspirin; ASAVLD, very-low-dose-aspirin; Ca, calcium; Cele, celecoxib (400 mg and 800 mg daily), PLB, placebo; VD, vitamin D

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us